Restore Mind Medicine

Questions to the Company for MM-110 Was Barrow aware of the FDA's requirement for "months-to-years" of safety data before increasing dosage 35x? ? If he was aware, why did he do this? And did he properly obtain patient consent given the FDA concerns? If not, why did he not read the FDA minutes prior to changing a clinical protocol, or call Dr. Freeman who was an advisor and ask Dr. Freeman if there was anything he needed to know? 40

View entire presentation